Valuation: Renata PLC

Market Cap 52.03B 424M 370M 350M 317M 594M 40.68B 598M 4.17B 1.61B 20.63B 1.59B 1.56B 66.28B P/E 2026 *
18.5x
P/E 2027 * 12.6x
Enterprise Value 52.03B 424M 370M 350M 317M 594M 40.68B 598M 4.17B 1.61B 20.63B 1.59B 1.56B 66.28B EV / Sales 2026 *
1.1x
EV / Sales 2027 * 0.94x
Free-Float
17.05%
Yield 2026 *
1.26%
Yield 2027 * 3.22%
1 day+0.87%
1 week-1.61%
Current month-1.39%
1 month-3.84%
3 months+3.35%
6 months+5.32%
Current year+15.77%
1 week 445.1
Extreme 445.1
461.9
1 month 445.1
Extreme 445.1
472
Current year 381.8
Extreme 381.8
488
1 year 372
Extreme 372
497.9
3 years 372
Extreme 372
1,217.9
5 years 372
Extreme 372
1,289.72
10 years 372
Extreme 372
1,289.72
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2001-12-31
Chairman 84 -
Director/Board Member - 2013-08-26
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%-1.61%-7.62%-62.76% 418M
+0.15%+1.24%+52.08%+97.65% 1,013B
+0.03%-0.68%+50.67%+65.55% 644B
-0.20%+5.52%+20.63%+72.57% 465B
+0.53%+3.42%+39.21%+38.70% 352B
+0.39%+2.22%+17.02%+23.87% 264B
+0.17%+2.19%+6.33%+10.93% 253B
+0.19%-4.28%+37.15%+44.35% 203B
-1.20%-6.64%-23.23%-59.10% 188B
+0.94%+0.71%+31.22%+95.16% 181B
Average +0.20%-1.09%+22.35%+32.69% 356.41B
Weighted average by Cap. +0.22%+0.01%+34.70%+59.66%

Financials

2026 *2027 *
Net sales 47.45B 387M 337M 319M 289M 541M 37.1B 546M 3.81B 1.47B 18.82B 1.45B 1.42B 60.45B 55.08B 449M 392M 371M 336M 628M 43.07B 633M 4.42B 1.71B 21.84B 1.69B 1.65B 70.18B
Net income 2.81B 22.91M 19.99M 18.92M 17.13M 32.08M 2.2B 32.33M 226M 87.09M 1.11B 86.06M 84.16M 3.58B 4.39B 35.76M 31.2M 29.52M 26.73M 50.06M 3.43B 50.45M 352M 136M 1.74B 134M 131M 5.59B
Net Debt - -
Logo Renata PLC
Renata PLC is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing, marketing and distribution of pharmaceuticals, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. It operates in several modalities, such as oral solids dosage forms, which include tablets, capsules, OROS, oral dispersible tablets; soft gels injectables, which include hormone injectables, general injectables and oncology injectables; inhalers, which include DPI and MDI, and nutraceutical products. Its offering includes anthelmintic, live vaccines, nutrition products, vitamins & minerals, anti-gout, anti-spasmodic, and anti-allergic. The Company has approximately 14 manufacturing facilities spread over three manufacturing sites.
Employees
8,366
Date Price Change Volume
26-09-16 BDT 453.60 +0.87% 5,700
26-09-15 BDT 449.70 +0.85% 10,220
26-09-14 BDT 445.90 -2.79% 19,798
26-09-13 BDT 458.70 -0.07% 19,132
26-09-10 BDT 459.00 -0.48% 10,964
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
453.60BDT
Average target price
615.05BDT
Spread / Average Target
+35.59%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENATA Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!